메뉴 건너뛰기




Volumn 355, Issue 9210, 2000, Pages 1115-1116

Temozolomide for malignant brain tumours

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CARMUSTINE; CYTOTOXIC AGENT; PHENOBARBITAL; PHENYTOIN; PROCARBAZINE; TEMOZOLOMIDE;

EID: 0034177472     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02055-9     Document Type: Note
Times cited : (28)

References (11)
  • 1
    • 85120135933 scopus 로고    scopus 로고
    • Central Brain Tumor Registry of the United States (CBTRUS). Annual Report, 1997.
  • 2
    • 85120111192 scopus 로고    scopus 로고
    • Harras E Cancer rates and risks 4th edn. 1996 United States Department of Health and Human Services, Public Health Service, National Institutes of Health (NIH), National Cancer Institute Bethesda, Maryland
    • (1996)
  • 3
    • 0030993717 scopus 로고    scopus 로고
    • Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials
    • ES Newlands MF Stevens SR Wedge Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials Cancer Treatment Rev 23 1997 35 61
    • (1997) Cancer Treatment Rev , vol.23 , pp. 35-61
    • Newlands, ES1    Stevens, MF2    Wedge, SR3
  • 4
    • 0030765194 scopus 로고    scopus 로고
    • Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma
    • M Bower ES Newlands NM Bleehen Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma Cancer Chemother Pharmacol 40 1997 484 488
    • (1997) Cancer Chemother Pharmacol , vol.40 , pp. 484-488
    • Bower, M1    Newlands, ES2    Bleehen, NM3
  • 5
    • 0030449301 scopus 로고    scopus 로고
    • The Charing Cross Hospital experience with temozolomide in patients with gliomas
    • ES Newlands SM O'Reilly MG Glaser The Charing Cross Hospital experience with temozolomide in patients with gliomas Eur J Cancer 32A 1996 2236 2241
    • (1996) Eur J Cancer , vol.32A , pp. 2236-2241
    • Newlands, ES1    O'Reilly, SM2    Glaser, MG3
  • 6
    • 0032188739 scopus 로고    scopus 로고
    • Phase I trial of temozolomide using an extended continuous oral schedule
    • CS Brock ES Newlands SR Wedge Phase I trial of temozolomide using an extended continuous oral schedule Cancer Res 58 1998 4363 4367
    • (1998) Cancer Res , vol.58 , pp. 4363-4367
    • Brock, CS1    Newlands, ES2    Wedge, SR3
  • 7
    • 0032855728 scopus 로고    scopus 로고
    • Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse
    • WKA Yung MD Prados R Yaya-Tur Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse J Clin Oncol 17 1999 2762 2771
    • (1999) J Clin Oncol , vol.17 , pp. 2762-2771
    • Yung, WKA1    Prados, MD2    Yaya-Tur, R3
  • 8
    • 0001684580 scopus 로고    scopus 로고
    • Randomized trial of Temodal versus procarbazine in glioblastoma multiforme at first relapse
    • A Yung VA Levin R Albright Randomized trial of Temodal versus procarbazine in glioblastoma multiforme at first relapse Proc ASCO 18 1999 139a
    • (1999) Proc ASCO , vol.18 , pp. 139a
    • Yung, A1    Levin, VA2    Albright, R3
  • 9
    • 0029664326 scopus 로고    scopus 로고
    • O6-benzylguanine enhances the sensitivity of a glioma xenograft with low O6-alkylguanine-DNA alkyltransferase activity to temozolomide and BCNU
    • SR Wedge ES Newlands O6-benzylguanine enhances the sensitivity of a glioma xenograft with low O6-alkylguanine-DNA alkyltransferase activity to temozolomide and BCNU Br J Cancer 73 1996 1049 1052
    • (1996) Br J Cancer , vol.73 , pp. 1049-1052
    • Wedge, SR1    Newlands, ES2
  • 10
    • 0032435612 scopus 로고    scopus 로고
    • DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma
    • HS Friedman RE McLendon T Kerby DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma J Clin Oncol 16 1998 3851 3857
    • (1998) J Clin Oncol , vol.16 , pp. 3851-3857
    • Friedman, HS1    McLendon, RE2    Kerby, T3
  • 11
    • 0033760366 scopus 로고    scopus 로고
    • A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide: a North American Brain Tumor Consortium Study
    • SC Schold JG Kuhn SM Chang A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide: a North American Brain Tumor Consortium Study Neuro-Oncology 2 2000 34 39
    • (2000) Neuro-Oncology , vol.2 , pp. 34-39
    • Schold, SC1    Kuhn, JG2    Chang, SM3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.